BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 6335774)

  • 1. [Effects of propranolol in the patient with liver cirrhosis and hemorrhage caused by esophageal varices].
    Esquivel López A; López Fuertes F; Perches Vega A; Salgado-Escobar JL
    Rev Gastroenterol Mex; 1984; 49(4):211-4. PubMed ID: 6335774
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of hemorrhage from esophageal varices in patients with liver cirrhosis by administration of propranolol].
    López Fuerte F; Cárdenas Rojas JA; Esquivel López A; Perches Vega A
    Rev Gastroenterol Mex; 1986; 51(4):187-90. PubMed ID: 3502507
    [No Abstract]   [Full Text] [Related]  

  • 3. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.
    Garcia-Tsao G; Sanyal AJ; Grace ND; Carey W; ;
    Hepatology; 2007 Sep; 46(3):922-38. PubMed ID: 17879356
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-pathogenetic and pharmacotherapeutic aspects of portal hypertension in liver cirrhosis].
    Ryss ES; Fishzon-Ryss IuI
    Ter Arkh; 1989; 61(8):65-8. PubMed ID: 2686074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy of portal hypertension due to cirrhosis.
    Benhamou JP; Lebrec D
    Semin Liver Dis; 1982 Aug; 2(3):227-32. PubMed ID: 6129706
    [No Abstract]   [Full Text] [Related]  

  • 8. [Per-rectal scintigraphy of the portal system with pertechnetate TC-99M: effect of propranolol on portosystemic collateral circulation in patients with cirrhosis. Part II].
    Bołdys H; Hartleb M; Rudzki K; Nowak A; Nowak S
    Pol Arch Med Wewn; 1994 Jul; 92(1):19-25. PubMed ID: 7971473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol and haemorrhage due to rupture of oesophageal varices.
    Dobrilla G; de Pretis G
    Hepatogastroenterology; 1984 Dec; 31(6):245-7. PubMed ID: 6394464
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of propranolol on portal hypertension].
    Kovacević N; Tomić D; Perisić-Savić M; Grbić R
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical and practical considerations in the treatment of portal hypertension secondary to hepatic cirrhosis.
    Bizer LS
    Am Surg; 1984 Oct; 50(10):524-9. PubMed ID: 6385791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta blocker prevention of hemorrhages from esophageal varices in liver cirrhosis].
    Hütteroth TH; Meyer zum Büschenfelde KH
    Dtsch Med Wochenschr; 1983 Apr; 108(14):549-51. PubMed ID: 6132804
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
    Zoller WG; Gross M
    Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Portal hypertension and gastrointestinal bleeding].
    Souerbruch T; Heller J
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S239-40. PubMed ID: 16435725
    [No Abstract]   [Full Text] [Related]  

  • 15. [Propranolol in the prevention of digestive bleeding in cirrhotic patients].
    Sotto A; Castro R; Glez Cansino J
    Acta Gastroenterol Latinoam; 1989; 19(1):15-20. PubMed ID: 2690549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary prevention of digestive hemorrhage in portal hypertension].
    Lebrec D
    Gastroenterol Clin Biol; 1997; 21(5):391-3. PubMed ID: 9208015
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy of portal hypertension and oesophageal varices.
    Hayes P; Bouchier IA
    Br J Hosp Med; 1984 Jul; 32(1):39-42. PubMed ID: 6146364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease.
    Zaman A; Hapke R; Flora K; Rosen HR; Benner K
    Am J Gastroenterol; 1999 Nov; 94(11):3292-6. PubMed ID: 10566732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The low incidence of bacterial infections could be a protective factor against variceal bleeding per se in hemodynamic responders to propranolol.
    Senzolo M; Cholongitas E; Marelli L; Thalheimer U; Patch D; Burroughs AK
    Am J Gastroenterol; 2006 Oct; 101(10):2436-7. PubMed ID: 17032210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.